COVID-19 Vaccine for Children: Registration begins Jan 1; Know eligibility criteria, docs required

Children willing to get the Covid-19 vaccine would require to present a student ID card as identification.

COVID-19 Vaccine for Children: The registration process for children of age group of 15 to 18 years will begin on the CoWin portal from January 1, 2022. As informed by the chief of the platform, Dr RS Sharma, children willing to get the Covid-19 vaccine would require to present a student ID card as identification. Stating that vaccination will begin from January 3, the official also said that there will be no change in the process of registration and administration, as compared to adults.

Where to register for COVID-19 Vaccine for Children?

The process of registration for the COVID-19 vaccine would be the same way as that for adults. Children between the age group of 15 to 18 have to register on the CoWin app in advance and book an appointment at a vaccination centre close to them. Students are allowed to use their student ID as proof for verification before vaccination.

Eligibility Criteria, documents required for COVID-19 Vaccine for Children

The process to get the COVID-19 vaccine administered for children is simple. Children born in the year 2007 or before will be eligible for vaccination and they can register on or after January 1. Students can use their school identity card as identity proof.

The nine documents that are acceptable are Aadhaar Card, Driving License, Health Insurance Smart Card (issued by Ministry of Labour), Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA) Job Card, PAN Card, Passbooks issued by Bank/Post Office, Passport, Pension Document, Voter ID.

Which COVID-9 vaccine will be available for children?

For now, Bharat Biotech's Covaxin is likely to be the only COVID-19 vaccine available for those in the age group of 15-18 years from January 3. The country's inoculation programme has not yet introduced Zydus Cadila's vaccine ZyCoV-D even for adults, though it had received emergency use authorisation from the drug regulator on August 20, making it the first vaccine that could be administered in the age group of 12-18 years in the country. The indigenously developed ZyCoV-D is the world's first DNA-based needle-free COVID-19 vaccine. “Zydus vaccine has three doses and Covaxin has two. They (People) will have the choice but they will have to see which vaccine a particular vaccination centre is offering. Choice will be there, but it will also depend on the availability at particular vaccination centres,” Sharma said.

Read More: